Cancer overtreatment raises concern; Physicians tend to use new technology even before solid evidence backs it

NewsGuard 100/100 Score
The Associated Press/Arizona Republic: "It's an unthinkable notion for a generation raised on the message that early cancer detection saves lives, but specialists say more tumors actually are being found too early. That is raising uncomfortable questions about how aggressively to treat early growths -- in some cases, even how aggressively to test -- along with a push for more of the informed-choice programs. … Today's cancer screenings can unearth tumors that scientists say never would have threatened the person's life. The problem is there aren't surefire ways to tell in advance which tumors won't be dangerous. ... Work is under way to better predict that, and even the staunchest supporters of screening call overdiagnosis a problem that needs tackling. ... Nowhere is the disconnect more obvious than with prostate cancer screening. Most men over 50 have had a PSA blood test to check for it even though major medical groups don't recommend routine PSAs, worried they may do more harm than good for the average man" (Neergaard, 6/15).

Meanwhile, Reuters reports that a lack "of solid evidence doesn't seem to hamper doctors' use of new technology, as long as they can get reimbursed for it, researchers said on Monday. They found that after the U.S. Congress had mandated Medicare coverage of a digital tool to help detect breast cancer, health providers were quick to pick it up even though it hadn't showed clear-cut benefits for the women. The technology, known as computer-aided detection, costs more than $100,000 to install, according to the researchers, whose findings are published in the Archives of Internal Medicine. … Based on Medicare data, [Joshua J.] Fenton, of the University of California, Davis, and his colleagues found that in 2001, doctors used computer-aided detection in less than 5 percent of screening mammograms. Two years later, that number had swollen more than five times" (6/14).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Machine learning models identify immunophenotypes in NSCLC for immunotherapy guidance